Free Trial

Chemed Co. (NYSE:CHE) Shares Purchased by Signal Advisors Wealth LLC

Chemed logo with Medical background

Signal Advisors Wealth LLC raised its position in Chemed Co. (NYSE:CHE - Free Report) by 28.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 6,412 shares of the company's stock after purchasing an additional 1,417 shares during the period. Signal Advisors Wealth LLC's holdings in Chemed were worth $3,945,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in CHE. Atala Financial Inc purchased a new position in shares of Chemed in the fourth quarter valued at $29,000. CBIZ Investment Advisory Services LLC increased its position in shares of Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after buying an additional 22 shares in the last quarter. Whipplewood Advisors LLC increased its position in shares of Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after buying an additional 18 shares in the last quarter. Tortoise Investment Management LLC increased its position in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after buying an additional 34 shares in the last quarter. Finally, Brown Brothers Harriman & Co. increased its position in shares of Chemed by 633.3% in the fourth quarter. Brown Brothers Harriman & Co. now owns 88 shares of the company's stock valued at $47,000 after buying an additional 76 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,500 shares of the stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $576.45, for a total transaction of $864,675.00. Following the transaction, the chief executive officer now directly owns 101,197 shares in the company, valued at approximately $58,335,010.65. This represents a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders have sold a total of 5,500 shares of company stock valued at $3,213,780 over the last quarter. Insiders own 3.29% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on CHE shares. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada raised their price target on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research report on Monday, April 28th.

Read Our Latest Analysis on CHE

Chemed Stock Down 0.3%

CHE opened at $559.79 on Friday. The firm has a market cap of $8.19 billion, a P/E ratio of 28.29, a PEG ratio of 2.15 and a beta of 0.54. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $623.61. The business's fifty day simple moving average is $576.96 and its 200 day simple moving average is $565.98.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The business had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business's revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter last year, the company earned $5.20 earnings per share. As a group, equities analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date is Thursday, May 29th. Chemed's payout ratio is currently 9.74%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines